DOCSLIB.ORG

Extracellular Purine Metabolism Is the Switchboard of Immunosuppressive

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Extracellular Purine Metabolism Is the Switchboard of Immunosuppressive ORIGINAL RESEARCH published: 27 April 2018 doi: 10.3389/fimmu.2018.00852 Extracellular Purine Metabolism Is the Switchboard of Immunosuppressive Edited by: Martin Herrmann, Macrophages and a Novel Target to Universitätsklinikum Erlangen, Germany Treat Diseases With Macrophage Reviewed by: Robert Adam Harris, Imbalances Karolinska Institute (KI), Sweden Anna Ohradanova-Repic1*, Christian Machacek 1, Celine Charvet 2,3,4†, Franck Lager 2,3,4, Amiram Ariel, Delphine Le Roux 2,3,4†, René Platzer 1, Vladimir Leksa1,5, Goran Mitulovic6, University of Haifa, Israel 7 8 9,10 2,3,4 Birgit Strobl, Thomas R. Burkard , Gerhard J. Zlabinger , Michael B. Fischer , Vincent Feuillet , 2,3,4 11 12 12 Veterinärmedizinische Gilles Renault , Stephan Blüml , Miroslav Benko , Miloslav Suchanek , Universität Wien, Austria Johannes B. Huppa1, Takami Matsuyama13, Artur Cavaco-Paulo14, Georges Bismuth2,3,4 1 *Correspondence: and Hannes Stockinger * Anna Ohradanova-Repic 1 Molecular Immunology Unit, Institute for Hygiene and Applied Immunology, Center for Pathophysiology, Infectiology and [email protected]; Immunology, Medical University of Vienna, Vienna, Austria, 2 Institut National de la Santé et de la Recherche Médicale, Hannes Stockinger INSERM U1016, Institut Cochin, Paris, France, 3 Université Paris Descartes, Paris, France, 4 Centre National de la Recherche hannes.stockinger@ Scientifique (CNRS), UMR 8104, Paris, France, 5 Laboratory of Molecular Immunology, Institute of Molecular Biology, Slovak meduniwien.ac.at Academy of Sciences, Bratislava, Slovakia, 6 Clinical Department of Medical and Chemical Laboratory Diagnostics, Medical †Present address: University of Vienna, Vienna, Austria, 7 Bioinformatics Department of the Research Institute of Molecular Pathology and the Celine Charvet, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria, 8 Institute of Immunology, Center IGBMC – CNRS UMR 7104 – for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria, 9 Department of Transfusion INSERM U964, Illkirch, France; Medicine, Medical University of Vienna, Vienna, Austria, 10 Center for Biomedical Technology, Danube University Krems, Delphine Le Roux, Krems, Austria, 11 Division of Rheumatology, Internal Medicine III, Medical University of Vienna, Vienna, Austria, 12 EXBIO Ecole Nationale Vétérinaire d’Alfort, Praha, Vestec, Czechia, 13 The Center for Advanced Biomedical Sciences and Swine Research, Kagoshima University, UMR BIPAR, Université Paris-Est, Kagoshima, Japan, 14 Centre of Biological Engineering, University of Minho, Campus of Gualtar, Braga, Portugal Maisons-Alfort, France Specialty section: If misregulated, macrophage (Mϕ)–T cell interactions can drive chronic inflammation thereby This article was submitted to causing diseases, such as rheumatoid arthritis (RA). We report that in a proinflammatory Molecular Innate Immunity, environment, granulocyte-M (GM-CSF)- and M colony-stimulating factor (M-CSF)- a section of the journal ϕ ϕ Frontiers in Immunology dependent Mϕs have dichotomous effects on T cell activity. While GM-CSF-dependent Received: 03 February 2018 Mϕs show a highly stimulatory activity typical for M1 Mϕs, M-CSF-dependent Mϕs, Accepted: 06 April 2018 marked by folate receptor β (FRβ), adopt an immunosuppressive M2 phenotype. We Published: 27 April 2018 find the latter to be caused by the purinergic pathway that directs release of extracellular Citation: ATP and its conversion to immunosuppressive adenosine by co-expressed CD39 Ohradanova-Repic A, Machacek C, Charvet C, Lager F, Le Roux D, and CD73. Since we observed a misbalance between immunosuppressive and immu- Platzer R, Leksa V, Mitulovic G, nostimulatory Mϕs in human and murine arthritic joints, we devised a new strategy for Burkard TR, Zlabinger GJ, Fischer MB, Feuillet V, Renault G, RA treatment based on targeted delivery of a novel methotrexate (MTX) formulation to Blüml S, Benko M, Suchanek M, the immunosuppressive FRβ+CD39+CD73+ Mϕs, which boosts adenosine production Huppa JB, Matsuyama T, and curtails the dominance of proinflammatory M s. In contrast to untargeted MTX, Cavaco-Paulo A, Bismuth G and ϕ Stockinger H (2018) Extracellular this approach leads to potent alleviation of inflammation in the murine arthritis model. Purine Metabolism Is the In conclusion, we define the ϕM extracellular purine metabolism as a novel checkpoint Switchboard of Immunosuppressive Macrophages and a Novel in Mϕ cell fate decision-making and an attractive target to control pathological Mϕs in Target to Treat Diseases With immune-mediated diseases. Macrophage Imbalances. Front. Immunol. 9:852. Keywords: macrophage polarization, chronic inflammation, macrophage-T cell interaction, purine metabolism, doi: 10.3389/fimmu.2018.00852 adenosine, methotrexate, rheumatoid arthritis Frontiers in Immunology | www.frontiersin.org 1 April 2018 | Volume 9 | Article 852 Ohradanova-Repic et al. Adenosine-Mediated Switch of M-CSF-Dependent M1 Mϕs INTRODUCTION To elucidate mechanisms how different ϕM subtypes contri- bute to chronic inflammation in RA and to identify pathways Macrophages (Mϕs) are myeloid immune cells essential for tissue controlling their identity, we aimed to generate variously activated homeostasis and immunity. Their differentiation and main tenance human GM-CSF- or M-CSF-differentiated ϕM s and address their is controlled in a tissue-specific manner mainly by two growth ability to produce inflammatory mediators and influence T cell factors, Mϕ and granulocyte-Mϕ colony-stimulating factor responses. We show that FRβ+ M-CSF-dependent Mϕs respond (M-CSF/CSF-1 and GM-CSF/CSF-2), respectively (1). In addi- to proinflammatory stimuli by modulating gene expression of tion, the Mϕ phenotype is further shaped by local stimuli, to the purinergic pathway as a means to produce and respond to which Mϕs respond with high plasticity (2). During infection or extracellular adenosine. Adenosine skews these cells toward the sterile inflammation, proinflammatory cyto kines, such as IFNγ, M2 state and suppresses autologous T cells. GM-CSF-dependent or toll-like receptor (TLR) ligands activate Mϕs into the proin- Mϕs resist this adenosine-mediated switch, so that only specific flammatory M1 type with microbicidal and tumoricidal activity. enhancement of the purinergic metabolism in the FRβ+ Mϕs Alternatively, Th2 cytokines IL-4/IL-13 promote M2 ϕM s with potently limits inflammation in the arthritis mouse model. a tissue remodeling or immunoregulatory phenotype, while stimulation with IL-10, transforming growth factor-β (TGF-β), or glucocorticoids generates highly immu nosuppressive “M2-like” MATERIALS AND METHODS Mϕs (3–5). The shift in theϕ M polarizing stimuli during the Reagents resolution phase of infection is thought to convert M1 Mϕs to the M2 type, restoring tissue homeos tasis (4, 6). LPS (Escherichia coli serotype O55:B5) and adenosine were pur- Recently, it has become apparent that ligation of TLRs or chased from Sigma-Aldrich (St. Louis, MO, USA). Deuterated cytokine receptors also triggers profound changes in key metabolic adenosine was from CDN Isotopes (Quebec, Canada). Adenosine events in Mϕs, enabling coordinate induction and maintenance 5′-triphosphate disodium salt (ATP) was from Thermo Fisher of Mϕ effector activities (7–9). In M1 Mϕs, aerobic glycolysis is Scientific (Waltham, MA, USA). Recombinant human M-CSF, induced to readily provide cells with energy in a form of adenosine IFNγ, and IL-10 were obtained from Peprotech (Rocky Hill, 5′-triphosphate (ATP). Aerobic glycolysis additionally feeds to NJ, USA). Recombinant human GM-CSF and IL-4 were from the pentose phosphate pathway for production of nucleotides and Novartis AG (Basel, Switzerland). The RPMI 1640 medium, NADPH, the latter being required for generation of microbicidal l-glutamine, streptomycin, penicillin, and heat-inactivated fetal reactive oxygen species (8, 9). Furthermore, the glycolytic switch calf serum (FCS) were obtained from Gibco, Thermo Fisher is associated with an increase in several metabolic intermediates Scientific. CD39 inhibitor POM-1 was from Tocris Bioscience that are incorporated into signaling pathways to support the (Bristol, UK). The cell proliferation dye CFSE and calcium inflammatory phenotype. In contrast, M2 ϕM s rely on oxidative sensor Fluo-4, AM was from Molecular Probes, Thermo Fisher metabolism that enables long-term cell survival and promotes Scientific. Brilliant Violet 421-conjugated streptavidin used M2 functions (7). Another example is l-arginine metabolism, as a second step in flow cytometry analyses was purchased which is a hallmark of differently polarized mouse ϕM s (10). from BioLegend (San Diego, CA, USA). Phorbol 12-myristate In M1 Mϕs, arginine is a substrate to nitric oxide synthase (NOS2) 13-acetate (PMA), ionomycin calcium salt (ionomycin) from induced by proinflammatory stimuli to produce antibacterial S. conglobatus and monensin A sodium salt (monensin) were NO. In M2 Mϕs, arginine is metabolized by the M2 marker argi- purchased from Sigma-Aldrich. nase 1 (Arg1) to urea and l-ornithine, a precursor of polyamines important for wound healing. Additionally, Arg1 action limits Antibodies arginine availability to bystander proliferating T cells, leading to The anti-FRβ monoclonal antibody (mAb) (clone EM-35) (17); their suppression (10). While these key metabolic differences was provided by EXBIO (Vestec, Czech Republic), either as between M1 and M2 Mϕs are widely accepted, the metabolic
Load more

Recommended publications
  • Protective Effects of Anthocyanins on the Ectonucleotidase Activity in the Impairment of Memory Induced by Scopolamine in Adult Rats
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Life Sciences 91 (2012) 1221–1228 Contents lists available at SciVerse ScienceDirect Life Sciences journal homepage: www.elsevier.com/locate/lifescie Protective effects of anthocyanins on the ectonucleotidase activity in the impairment of memory induced by scopolamine in adult rats Jessié M. Gutierres a,⁎, Fabiano B. Carvalho a, Maria R.C. Schetinger a, Marília V. Rodrigues a, Roberta Schmatz a, Victor C. Pimentel a, Juliano M. Vieira a, Michele M. Rosa a, Patrícia Marisco a, Daniela A. Ribeiro a, Claudio Leal a, Maribel A. Rubin a, Cinthia M. Mazzanti c, Roselia Spanevello b,⁎⁎ a Departamento de Química, Universidade Federal de Santa Maria, Santa Maria, RS 97105-900, Brazil b Centro de Ciências Químicas, Farmacêuticas e de Alimentos, Universidade Federal de Pelotas, Campus Universitário-Capão do Leão 96010-900 Pelotas, RS, Brazil c Clínica de Pequenos animais, Centro de Ciências Rurais, Universidade Federal de Santa Maria, Santa Maria, RS 97105-900, Brazil article info abstract Article history: Aims: We investigated whether the treatment with anthocyanins prevents the scopolamine-induced memory Received 24 March 2012 deficits and whether ectonucleotidase activities and purine levels are altered in the cerebral cortex (CC) and Accepted 19 September 2012 hippocampus (HC) in this model of mnemonic deficit in rats. Main methods: The animals were divided into 4 experimental groups: control (vehicle), anthocyanins (Antho), Keywords: scopolamine (SCO), and scopolamine plus anthocyanins (SCO+Antho). After seven days of treatment, they Anthocyanins were tested in the inhibitory avoidance task and open field test and submitted to euthanasia.
    [Show full text]
  • 35 Disorders of Purine and Pyrimidine Metabolism
    35 Disorders of Purine and Pyrimidine Metabolism Georges van den Berghe, M.- Françoise Vincent, Sandrine Marie 35.1 Inborn Errors of Purine Metabolism – 435 35.1.1 Phosphoribosyl Pyrophosphate Synthetase Superactivity – 435 35.1.2 Adenylosuccinase Deficiency – 436 35.1.3 AICA-Ribosiduria – 437 35.1.4 Muscle AMP Deaminase Deficiency – 437 35.1.5 Adenosine Deaminase Deficiency – 438 35.1.6 Adenosine Deaminase Superactivity – 439 35.1.7 Purine Nucleoside Phosphorylase Deficiency – 440 35.1.8 Xanthine Oxidase Deficiency – 440 35.1.9 Hypoxanthine-Guanine Phosphoribosyltransferase Deficiency – 441 35.1.10 Adenine Phosphoribosyltransferase Deficiency – 442 35.1.11 Deoxyguanosine Kinase Deficiency – 442 35.2 Inborn Errors of Pyrimidine Metabolism – 445 35.2.1 UMP Synthase Deficiency (Hereditary Orotic Aciduria) – 445 35.2.2 Dihydropyrimidine Dehydrogenase Deficiency – 445 35.2.3 Dihydropyrimidinase Deficiency – 446 35.2.4 Ureidopropionase Deficiency – 446 35.2.5 Pyrimidine 5’-Nucleotidase Deficiency – 446 35.2.6 Cytosolic 5’-Nucleotidase Superactivity – 447 35.2.7 Thymidine Phosphorylase Deficiency – 447 35.2.8 Thymidine Kinase Deficiency – 447 References – 447 434 Chapter 35 · Disorders of Purine and Pyrimidine Metabolism Purine Metabolism Purine nucleotides are essential cellular constituents 4 The catabolic pathway starts from GMP, IMP and which intervene in energy transfer, metabolic regula- AMP, and produces uric acid, a poorly soluble tion, and synthesis of DNA and RNA. Purine metabo- compound, which tends to crystallize once its lism can be divided into three pathways: plasma concentration surpasses 6.5–7 mg/dl (0.38– 4 The biosynthetic pathway, often termed de novo, 0.47 mmol/l). starts with the formation of phosphoribosyl pyro- 4 The salvage pathway utilizes the purine bases, gua- phosphate (PRPP) and leads to the synthesis of nine, hypoxanthine and adenine, which are pro- inosine monophosphate (IMP).
    [Show full text]
  • The Biochemistry of Gout: a USMLE Step 1 Study Aid
    The Biochemistry of Gout: A USMLE Step 1 Study Aid BMS 6204 May 26, 2005 Compiled by: Todd Kerensky Elizabeth Ballard Brendan Prendergast Eric Ritchie 1 Introduction Gout is a systemic disease caused by excess uric acid as the result of deficient purine metabolism. Clinically, gout is marked by peripheral arthritis and painful inflammation in joints resulting from deposition of uric acid in joint synovia as monosodium urate crystals. Although gout is the most common crystal-induced arthritis, a condition known as pseudogout can commonly be mistaken for gout in the clinic. Pseudogout results from deposition of calcium pyrophosphatase (CPP) crystals in synovial spaces, but causes nearly identical clinical presentation. Clinical findings Crystal-induced arthritis such as gout and pseudogout differ from other types of arthritis in their clinical presentations. The primary feature differentiating gout from other types of arthritis is the spontaneity and abruptness of onset of inflammation. Additionally, the inflammation from gout and pseudogout are commonly found in a single joint. Gout and pseudogout typically present with Podagra, a painful inflammation of the metatarsal- phalangeal joint of the great toe. However, gout can also present with spontaneous edema and painful inflammation of any other joint, but most commonly the ankle, wrist, or knee. As an exception, a spontaneous painful inflammation in the glenohumeral joint is usually the result of pseudogout. It is important to recognize the clinical differences between gout, pseudogout and other types of arthritis because the treatments differ markedly (Kaplan 2005). Pathophysiology and Treatment of Gout Although gout affects peripheral joints in clinical presentation, it is important to recognize that it is a systemic disorder caused by either overproduction or underexcretion of uric acid.
    [Show full text]
  • Ectonucleotidase Expression on Human Amnion Epithelial Cells
    Ectonucleotidase Expression on Human Amnion Epithelial Cells: Adenosinergic Pathways and Dichotomic Effects on Immune Effector Cell Populations This information is current as of September 28, 2021. Fabio Morandi, Alberto L. Horenstein, Valeria Quarona, Angelo Corso Faini, Barbara Castella, Raghuraman C. Srinivasan, Stephen C. Strom, Fabio Malavasi and Roberto Gramignoli J Immunol published online 26 December 2018 Downloaded from http://www.jimmunol.org/content/early/2018/12/23/jimmun ol.1800432 http://www.jimmunol.org/ Supplementary http://www.jimmunol.org/content/suppl/2018/12/23/jimmunol.180043 Material 2.DCSupplemental Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists by guest on September 28, 2021 • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2018 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Published December 26, 2018, doi:10.4049/jimmunol.1800432 The Journal of Immunology Ectonucleotidase Expression on Human Amnion Epithelial Cells: Adenosinergic Pathways and Dichotomic Effects on Immune Effector Cell Populations Fabio Morandi,*,1 Alberto L. Horenstein,†,‡,x,1 Valeria Quarona,† Angelo Corso Faini,† Barbara Castella,† Raghuraman C.
    [Show full text]
  • The Link Between Purine Metabolism and Production of Antibiotics in Streptomyces
    antibiotics Review The Link between Purine Metabolism and Production of Antibiotics in Streptomyces Smitha Sivapragasam and Anne Grove * Department of Biological Sciences, Louisiana State University, Baton Rouge, LA 70803, USA; [email protected] * Correspondence: [email protected] Received: 10 May 2019; Accepted: 3 June 2019; Published: 6 June 2019 Abstract: Stress and starvation causes bacterial cells to activate the stringent response. This results in down-regulation of energy-requiring processes related to growth, as well as an upregulation of genes associated with survival and stress responses. Guanosine tetra- and pentaphosphates (collectively referred to as (p)ppGpp) are critical for this process. In Gram-positive bacteria, a main function of (p)ppGpp is to limit cellular levels of GTP, one consequence of which is reduced transcription of genes that require GTP as the initiating nucleotide, such as rRNA genes. In Streptomycetes, the stringent response is also linked to complex morphological differentiation and to production of secondary metabolites, including antibiotics. These processes are also influenced by the second messenger c-di-GMP. Since GTP is a substrate for both (p)ppGpp and c-di-GMP, a finely tuned regulation of cellular GTP levels is required to ensure adequate synthesis of these guanosine derivatives. Here, we discuss mechanisms that operate to control guanosine metabolism and how they impinge on the production of antibiotics in Streptomyces species. Keywords: c-di-GMP; guanosine and (p)ppGpp; purine salvage; secondary metabolism; Streptomycetes; stringent response 1. Introduction Bacteria experience constant challenges, either in the environment or when infecting a host. They utilize various mechanisms to survive such stresses, which may include changes in temperature, pH, or oxygen content as well as limited access to carbon or nitrogen sources.
    [Show full text]
  • Characterization of the Contractile P2Y14 Receptor in Mouse Coronary and Cerebral Arteries ⇑ Kristian Agmund Haanes , Lars Edvinsson
    FEBS Letters 588 (2014) 2936–2943 journal homepage: www.FEBSLetters.org Characterization of the contractile P2Y14 receptor in mouse coronary and cerebral arteries ⇑ Kristian Agmund Haanes , Lars Edvinsson Department of Clinical Experimental Research, Glostrup Research Institute, Copenhagen University Hospital, Nordre Ringvej 59, 2600 Glostrup, Denmark article info abstract Article history: Extracellular UDP-glucose can activate the purinergic P2Y14 receptor. The aim of the present study Received 13 February 2014 was to examine the physiological importance of P2Y14 receptors in the vasculature. The data pre- Revised 13 May 2014 sented herein show that UDP-glucose causes contraction in mouse coronary and basilar arteries. Accepted 21 May 2014 The EC values and immunohistochemistry illustrated the strongest P2Y14 receptor expression in Available online 6 June 2014 50 the basilar artery. In the presence of pertussis toxin, UDP-glucose inhibited contraction in coronary Edited by Ned Mantei arteries and in the basilar artery it surprisingly caused relaxation. After organ culture of the coro- nary artery, the EC50 value decreased and an increased staining for the P2Y14 receptor was observed, showing receptor plasticity. Keywords: Purinergic receptors Ó 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved. P2Y14 Coronary artery Basilar artery Receptor upregulation P2Y2 KO 1. Introduction vasoconstriction in porcine pancreatic arteries [12]. This study was designed to examine the physiological importance
    [Show full text]
  • Effects of Allopurinol and Oxipurinol on Purine Synthesis in Cultured Human Cells
    Effects of allopurinol and oxipurinol on purine synthesis in cultured human cells William N. Kelley, James B. Wyngaarden J Clin Invest. 1970;49(3):602-609. https://doi.org/10.1172/JCI106271. Research Article In the present study we have examined the effects of allopurinol and oxipurinol on thed e novo synthesis of purines in cultured human fibroblasts. Allopurinol inhibits de novo purine synthesis in the absence of xanthine oxidase. Inhibition at lower concentrations of the drug requires the presence of hypoxanthine-guanine phosphoribosyltransferase as it does in vivo. Although this suggests that the inhibitory effect of allopurinol at least at the lower concentrations tested is a consequence of its conversion to the ribonucleotide form in human cells, the nucleotide derivative could not be demonstrated. Several possible indirect consequences of such a conversion were also sought. There was no evidence that allopurinol was further utilized in the synthesis of nucleic acids in these cultured human cells and no effect of either allopurinol or oxipurinol on the long-term survival of human cells in vitro could be demonstrated. At higher concentrations, both allopurinol and oxipurinol inhibit the early steps ofd e novo purine synthesis in the absence of either xanthine oxidase or hypoxanthine-guanine phosphoribosyltransferase. This indicates that at higher drug concentrations, inhibition is occurring by some mechanism other than those previously postulated. Find the latest version: https://jci.me/106271/pdf Effects of Allopurinol and Oxipurinol on Purine Synthesis in Cultured Human Cells WILLIAM N. KELLEY and JAMES B. WYNGAARDEN From the Division of Metabolic and Genetic Diseases, Departments of Medicine and Biochemistry, Duke University Medical Center, Durham, North Carolina 27706 A B S TR A C T In the present study we have examined the de novo synthesis of purines in many patients.
    [Show full text]
  • Ectonucleotidase Activities in Sertoli Cells from Immature Rats
    Brazilian Journal of Medical and Biological Research (2001) 34: 1247-1256 Ectonucleotidases in Sertoli cells 1247 ISSN 0100-879X Ectonucleotidase activities in Sertoli cells from immature rats E.A. Casali, T.R. da Silva, Departamento de Bioquímica, Instituto de Ciências Básicas da Saúde, D.P. Gelain, G.R.R.F. Kaiser, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brasil A.M.O. Battastini, J.J.F. Sarkis and E.A. Bernard Abstract Correspondence Sertoli cells have been shown to be targets for extracellular purines Key words E.A. Bernard such as ATP and adenosine. These purines evoke responses in Sertoli · Sertoli cells Departamento de Bioquímica · Purine nucleotides cells through two subtypes of purinoreceptors, P2Y2 and PA1. The Rua Ramiro Barcellos, 2600, Anexo · signals to purinoreceptors are usually terminated by the action of ATP diphosphohydrolase 90035-003 Porto Alegre, RS · Ecto-5’-nucleotidase ectonucleotidases. To demonstrate these enzymatic activities, we Brasil · Ectoadenosine deaminase Fax: +55-51-316-5540 cultured rat Sertoli cells for four days and then used them for different E-mail: [email protected] assays. ATP, ADP and AMP hydrolysis was estimated by measuring the Pi released using a colorimetric method. Adenosine deaminase activity (EC 3.5.4.4) was determined by HPLC. The cells were not disrupted after 40 min of incubation and the enzymatic activities were Received September 6, 2000 considered to be ectocellularly localized. ATP and ADP hydrolysis Accepted July 2, 2001 was markedly increased by the addition of divalent cations to the reaction medium. A competition plot demonstrated that only one enzymatic site is responsible for the hydrolysis of ATP and ADP.
    [Show full text]
  • P2X7 in Cancer: from Molecular Mechanisms to Therapeutics
    REVIEW published: 04 June 2020 doi: 10.3389/fphar.2020.00793 P2X7 in Cancer: From Molecular Mechanisms to Therapeutics Romain Lara 1*, Elena Adinolfi 2, Catherine A. Harwood 3, Mike Philpott 4, Julian A. Barden 5, Francesco Di Virgilio 6 and Shaun McNulty 1 1 Biosceptre (UK) Limited, Cambridge, United Kingdom, 2 Department of Medical Sciences, University of Ferrara, Ferrara, Italy, 3 Centre for Cell Biology and Cutaneous Research, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom, 4 Centre for Cutaneous Research, Blizard Institute, Bart’s & The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom, 5 Biosceptre (Australia) Pty Ltd., Sydney, NSW, Australia, 6 Department of Morphology, Surgery and Experimental Medicine, Section of Pathology, Oncology and Experimental Biology, University of Ferrara, Ferrara, Italy P2X7 is a transmembrane receptor expressed in multiple cell types including neurons, dendritic cells, macrophages, monocytes, B and T cells where it can drive a wide range of physiological responses from pain transduction to immune response. Upon activation by Edited by: its main ligand, extracellular ATP, P2X7 can form a nonselective channel for cations to Stefan Feske, enter the cell. Prolonged activation of P2X7, via high levels of extracellular ATP over an New York University, United States extended time period can lead to the formation of a macropore, leading to depolarization Reviewed by: Friedrich Haag, of the plasma membrane and ultimately to cell death. Thus, dependent on its activation University Medical Center Hamburg- state, P2X7 can either drive cell survival and proliferation, or induce cell death.
    [Show full text]
  • Study of Purine Metabolism in a Xanthinuric Female
    Study of Purine Metabolism in a Xanthinuric Female MICHAEL J. BRADFORD, IRWIN H. KRAKOFF, ROBERT LEEPER, and M. EARL BALis From the Sloan-Kettering Institute, Sloan-Kettering Division of Cornell University Graduate School of Medical Sciences, and the Department of Medicine of Memorial and James Ewing Hospitals, New York 10021 A B S TR A C T A case of xanthinuria is briefly de- Case report in brief. The patient is a 62 yr old scribed, and the results of in vivo studies with Puerto Rican grandmother, whose illness is de- 4C-labeled oxypurines are discussed. The data scribed in detail elsewhere.' Except for mild pso- demonstrate that the rate of the turnover of uric riasis present for 30 yr, she has been in good acid is normal, despite an extremely small uric health. On 26 June 1966, the patient was admitted acid pool. Xanthine and hypoxanthine pools were to the Second (Cornell) Medical Service, Bellevue measured and their metabolism evaluated. The Hospital, with a 3 day history of pain in the right bulk of the daily pool of 276 mg of xanthine, but foot and fever. The admission physical examina- only 6% of the 960 mg of hypoxanthine, is ex- tion confirmed the presence of monoarticular ar- creted. Thus, xanthine appears to be a metabolic thritis and mild psoriasis. The patient's course in end product, whereas hypoxanthine is an active the hospital was characterized by recurrent fevers intermediate. Biochemical implications of this find- to 104°F and migratory polyarthritis, affecting ing are discussed. both ankles, knees, elbows, wrists, and hands over a 6 wk period.
    [Show full text]
  • ATP Release from Human Airway Epithelial Cells Exposed to Staphylococcus Aureus Alpha-Toxin
    toxins Article ATP Release from Human Airway Epithelial Cells Exposed to Staphylococcus aureus Alpha-Toxin Romina Baaske, Mandy Richter, Nils Möller, Sabine Ziesemer, Ina Eiffler, Christian Müller and Jan-Peter Hildebrandt * Animal Physiology and Biochemistry, Ernst Moritz Arndt-University, Felix Hausdorff-Strasse 1, B.10.06, D-17489 Greifswald, Germany; [email protected] (R.B.); [email protected] (M.R.); [email protected] (N.M.); [email protected] (S.Z.); ina.eiffl[email protected] (I.E.); [email protected] (C.M.) * Correspondence: [email protected]; Tel.: +49-3834-86-4295; Fax: +49-3834-86-4261 Academic Editor: Vernon L. Tesh Received: 6 January 2016; Accepted: 1 December 2016; Published: 6 December 2016 Abstract: Airway epithelial cells reduce cytosolic ATP content in response to treatment with S. aureus alpha-toxin (hemolysin A, Hla). This study was undertaken to investigate whether this is due to attenuated ATP generation or to release of ATP from the cytosol and extracellular ATP degradation by ecto-enzymes. Exposure of cells to rHla did result in mitochondrial calcium uptake and a moderate decline in mitochondrial membrane potential, indicating that ATP regeneration may have been attenuated. In addition, ATP may have left the cells through transmembrane pores formed by the toxin or through endogenous release channels (e.g., pannexins) activated by cellular stress imposed on the cells by toxin exposure. Exposure of cells to an alpha-toxin mutant (H35L), which attaches to the host cell membrane but does not form transmembrane pores, did not induce ATP release from the cells.
    [Show full text]
  • Implications of Oxidative Stress in Glioblastoma Multiforme Following Treatment with Purine Derivatives
    antioxidants Article Implications of Oxidative Stress in Glioblastoma Multiforme Following Treatment with Purine Derivatives Marta Orlicka-Płocka 1,† , Agnieszka Fedoruk-Wyszomirska 1,† , Dorota Gurda-Wo´zna 1 , Paweł Pawelczak 1 , Patrycja Krawczyk 2, Małgorzata Giel-Pietraszuk 1, Grzegorz Framski 1 , Tomasz Ostrowski 1 and Eliza Wyszko 1,* 1 Institute of Bioorganic Chemistry, Polish Academy of Sciences, Noskowskiego 12/14, 61-704 Poznan, Poland; [email protected] (M.O.-P.); [email protected] (A.F.-W.); [email protected] (D.G.-W.); [email protected] (P.P.); [email protected] (M.G.-P.); [email protected] (G.F.); [email protected] (T.O.) 2 MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 0QH, UK; [email protected] * Correspondence: [email protected] † Equally contributed as the first author. Abstract: Recently, small compound-based therapies have provided new insights into the treatment of glioblastoma multiforme (GBM) by inducing oxidative impairment. Kinetin riboside (KR) and newly designed derivatives (8-azaKR, 7-deazaKR) selectively affect the molecular pathways crucial for cell growth by interfering with the redox status of cancer cells. Thus, these compounds might serve as potential alternatives in the oxidative therapy of GBM. The increased basal levels of reactive oxygen species (ROS) in GBM support the survival of cancer cells and cause drug resistance. The simplest Citation: Orlicka-Płocka, M.; approach to induce cell death is to achieve the redox threshold and circumvent the antioxidant Fedoruk-Wyszomirska, A.; defense mechanisms. Consequently, cells become more sensitive to oxidative stress (OS) caused by Gurda-Wo´zna,D.; Pawelczak, P.; exogenous agents.
    [Show full text]